<DOC>
	<DOCNO>NCT00761007</DOCNO>
	<brief_summary>The purpose study evaluate benefit treatment oral dose Ibodutant ( code : MEN 15596 ) IBS symptom safety tolerability therapy .</brief_summary>
	<brief_title>Ibodutant Relief Irritable Bowel Syndrome ( IRIS )</brief_title>
	<detailed_description>Irritable Bowel Syndrome ( IBS ) functional disorder characterise chronic recurrent abdominal pain discomfort associate alter bowel habit . This trial aim evaluate efficacy Ibodutant improvement IBS symptom daily oral administration , test three dosage placebo IBS patient 4-weeks . In patient , experimental clinical phase encompass screening/ 2-week run-in period ( study medication ) , follow 4-weeks treatment period 2-weeks treatment withdrawal period , total study duration 8 week patient .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>1 . Male female patient age 18 70 year . 2 . Clinical diagnosis IBS . 3 . For patient old 50 year patient positive family history colorectal cancer : normal result colonoscopy flexible sigmoidoscopy . 4 . Use appropriate contraceptive method . 5 . Normal physical examination without clinically relevant abnormality . 1 . Patients organic abnormality gastrointestinal tract include history colonic major abdominal surgery , current previous diagnosis neoplasia , inflammatory bowel disease , symptomatic gallbladder stone disease , diverticulosis/diverticulitis , ectopic endometriosis . 2 . History gluten enteropathy . 3 . Lactose intolerance assess response diet 4 . Diagnosis ova parasite , occult blood stool previous 6 month . 5 . Previous diagnosis Diabetes Mellitus ( either type 1 2 ) 6 . Unstable medical condition . 7 . Concomitant medication within 7 day prior screen drug know interfere gastrointestinal motility sensitivity . 8 . Pregnancy breastfeed . 9 . Patient able understand collaborate throughout study . 10 . Participation clinical trial previous 4 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Irritable Bowel Syndrome</keyword>
	<keyword>Bowel disease</keyword>
</DOC>